Ciprofloxacin Extended-Release Tablets: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Dr. Reddy's Laboratories, Inc.
Country: India
Condition: Anthrax, Anthrax Prophylaxis, Bacteremia, Bacterial Infection, Bladder Infection, Bone infection (Osteomyelitis), Bronchiectasis, Bronchitis, Chancroid, Cholera, Cutaneous Bacillus anthracis, Diverticulitis, Epididymitis, Sexually Transmitted, Febrile Neutropenia, Granuloma Inguinale, Gonococcal Infection, Uncomplicated, Gonococcal Infection, Disseminated, Infection Prophylaxis, Infectious Diarrhea, Intraabdominal Infection, Joint Infection, Kidney Infections (Pyelonephritis), Meningococcal Meningitis Prophylaxis, Mycobacterium avium-intracellulare, Treatment, Nosocomial Pneumonia, Peritonitis, Plague, Plague Prophylaxis, Pneumonia, Pneumonia with Cystic Fibrosis, Prostatitis, Pouchitis, Rabbit Fever (Tularemia), Salmonella Enteric Fever, Salmonella Gastroenteritis, Shigellosis, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection, Surgical Prophylaxis, Typhoid Fever, Tuberculosis, Active, Traveler's Diarrhea, Urinary Tract Infection
Class: Antibiotics/antineoplastics, Quinolones
Form: Tablets
Ingredients: ciprofloxacin, colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, sodium starch glycolate, corn starch, titanium dioxide; crospovidone, colloidal silicon dioxide, ethylcellulose, hypromellose, magnesium stearate, polyethylene glycol, succinic acid, titanium dioxide